Safety of RG2077 in Patients With Multiple Sclerosis
Clinical trial NCT00076934 · COMPLETED
Trial details
- NCT number
- NCT00076934
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2003-01-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.